IL96904A0 - Oral pharmaceutical compositions in unit dosage form comprising bismuth subcitrate - Google Patents

Oral pharmaceutical compositions in unit dosage form comprising bismuth subcitrate

Info

Publication number
IL96904A0
IL96904A0 IL96904A IL9690491A IL96904A0 IL 96904 A0 IL96904 A0 IL 96904A0 IL 96904 A IL96904 A IL 96904A IL 9690491 A IL9690491 A IL 9690491A IL 96904 A0 IL96904 A0 IL 96904A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
dosage form
unit dosage
oral pharmaceutical
bismuth subcitrate
Prior art date
Application number
IL96904A
Other languages
English (en)
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of IL96904A0 publication Critical patent/IL96904A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/29Antimony or bismuth compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL96904A 1990-01-09 1991-01-08 Oral pharmaceutical compositions in unit dosage form comprising bismuth subcitrate IL96904A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90200064 1990-01-09

Publications (1)

Publication Number Publication Date
IL96904A0 true IL96904A0 (en) 1992-03-29

Family

ID=8204917

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96904A IL96904A0 (en) 1990-01-09 1991-01-08 Oral pharmaceutical compositions in unit dosage form comprising bismuth subcitrate

Country Status (18)

Country Link
US (1) US5264222A (de)
EP (1) EP0437294B1 (de)
KR (1) KR910014124A (de)
AT (1) ATE101039T1 (de)
AU (1) AU638083B2 (de)
CA (1) CA2033870A1 (de)
DE (1) DE69101111T2 (de)
DK (1) DK0437294T3 (de)
ES (1) ES2063432T3 (de)
FI (1) FI910088A7 (de)
HU (1) HU204707B (de)
IE (1) IE910057A1 (de)
IL (1) IL96904A0 (de)
MY (1) MY106371A (de)
NO (1) NO910080L (de)
NZ (1) NZ236721A (de)
PT (1) PT96437A (de)
ZA (1) ZA91178B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
WO1997007757A1 (en) * 1995-08-24 1997-03-06 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms
CA2271799A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
HUP9904073A3 (en) * 1996-11-22 2000-04-28 Procter & Gamble Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
US20210106648A1 (en) * 2019-10-11 2021-04-15 TOBEBIO Novel Drug Laboratory Co., Ltd. Synergistic combination of chemotherapy and peptide for treating cancer
CN111214443A (zh) * 2020-02-23 2020-06-02 北京鑫开元医药科技有限公司 一种枸橼酸铋钾颗粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4670245A (en) * 1984-04-27 1987-06-02 Vasquez Tony E Diagnostic procedures using radiolabeled colloidal bismuth subcitrate and related compounds
CA1207239A (en) * 1984-08-10 1986-07-08 Upendra K. Banik Gastrointestinal compositions
JPS62502967A (ja) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
GB8612401D0 (en) * 1986-05-21 1986-06-25 Evode Ltd Liquid polmers
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
EP0375068A1 (de) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Mischungen von Bismuth-Verbindungen und Tetracyclinen

Also Published As

Publication number Publication date
FI910088L (fi) 1991-07-10
KR910014124A (ko) 1991-08-31
ATE101039T1 (de) 1994-02-15
AU6869391A (en) 1991-07-11
DE69101111T2 (de) 1994-07-28
MY106371A (en) 1995-05-30
ZA91178B (en) 1991-10-30
FI910088A7 (fi) 1991-07-10
AU638083B2 (en) 1993-06-17
EP0437294B1 (de) 1994-02-02
CA2033870A1 (en) 1991-07-10
ES2063432T3 (es) 1995-01-01
NZ236721A (en) 1992-08-26
EP0437294A1 (de) 1991-07-17
IE910057A1 (en) 1991-07-17
US5264222A (en) 1993-11-23
NO910080L (no) 1991-07-10
HU204707B (en) 1992-02-28
NO910080D0 (no) 1991-01-08
DK0437294T3 (da) 1994-03-07
FI910088A0 (fi) 1991-01-07
DE69101111D1 (de) 1994-03-17
PT96437A (pt) 1991-10-15

Similar Documents

Publication Publication Date Title
IL96904A0 (en) Oral pharmaceutical compositions in unit dosage form comprising bismuth subcitrate
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
EP0494972A4 (en) Effervescent dosage form and method of administering same
BR1100776A (pt) Forma de dosagem farmacêutica comprimida e obréia farmacêutica comprimida.
IE862554L (en) Pharmaceutical compositions
NZ242061A (en) Inhaler for powdered medicament
GB9016789D0 (en) Medicament administering devices
IL113818A0 (en) Pharmaceutical active cns compounds and pharmaceutical compositions containing them
IL101068A0 (en) Trans-pt(iv)complexes,their preparation and pharmaceutical compositions containing them
CA2108455A1 (en) Pharmaceutical compositions against gastric disorders
IL88670A0 (en) 2,5-diaryl-tetrahydrofurans and analogs thereof and pharmaceutical compositions containing them
GB9410236D0 (en) Cytotoxic drug therapy
IL103516A0 (en) Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them
IL90864A0 (en) Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them
IL89752A0 (en) Bisphosphonates,their production and pharmaceutical compositions containing them
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
NZ225393A (en) Cyclodextrin/bis-biguanido hexane complexes and pharmaceutical compositions containing them
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
IL91087A0 (en) Platinum-(iv)-diamine complexes,their preparation and pharmaceutical compositions containing them
IL105774A (en) N-(substituted 2-pyridyl)-6-chloro-4-hydroxy-2-methyl-2h-thieno 2, 3-e9-1, 2-thiazine-3-carboxamide, 1, 1-dioxides their preparation and pharmaceutical compositions containing them
NZ239222A (en) Pharmaceutical capsules and tablets containing ifosfamide
IL91737A0 (en) 2,7-diamino-1,2,3,4-tetrahydro-naphthalenes,their preparation and pharmaceutical compositions containing them